Efficacy and Toxicity of Triweekly Versus Weekly Cisplatin in Concurrent Chemoradiotherapy for Nasopharyngeal Carcinoma

This retrospective study compared the efficacy and toxicity of concurrent triweekly versus weekly cisplatin in patients with previously untreated, biopsy-proven NPC who received definitive CRT followed by adjuvant chemotherapy. Patients with distant metastasis, Karnofsky Performance Status < 80, induction chemotherapy, or no adjuvant therapy were excluded....

Continue reading at PubMed

✦ The floor

Discussion

Signed responses from readers of the wire.

✦ Clinical Takeaway ✦

Audiologists involved in ototoxicity monitoring programs for head and neck cancer patients should note this comparison, as dosing schedule may influence the degree of cisplatin-related hearing damage — but the retrospective design limits definitive guidance.

✦ Why It Matters ✦

Determining which cisplatin schedule causes less hearing damage without compromising cancer control is critical for audiologists co-managing ototoxicity surveillance in oncology settings.

✦ Key Points ✦

01Retrospective study comparing triweekly vs. weekly cisplatin in chemoradiotherapy for nasopharyngeal carcinoma.
02Ototoxicity (medication-related hearing damage) is a clinically significant toxicity outcome examined in the study.
03Published in International Journal of Cancer (PMID 42706851, DOI 10.1002/ijc.70723).
04Findings could inform oncology team decisions affecting audiological monitoring protocols.
05Retrospective design limits strength of causal conclusions about hearing outcomes.

✦ Claims & Evidence ✦

ClaimEvidenceSupport

Triweekly and weekly cisplatin schedules differ in their ototoxicity profiles when used in concurrent chemoradiotherapy for nasopharyngeal carcinoma.

studypartially supported

The two cisplatin dosing schedules differ in anti-tumour efficacy in nasopharyngeal carcinoma.

studypartially supported

✦ Research metadata ✦

PMID: 42706851
DOI: 10.1002/ijc.70723.
Journal: International Journal of Cancer
Publication type: research_article
Evidence level: 2b
Population: Patients with nasopharyngeal carcinoma receiving concurrent chemoradiotherapy
Intervention: Triweekly cisplatin in concurrent chemoradiotherapy
Comparator: Weekly cisplatin in concurrent chemoradiotherapy

Primary outcomes

Anti-tumour efficacy; Toxicity including ototoxicity

✦ Related stories ✦

PubMed·Clinical trial·Clinical audiology·11d ago

Hearing Intervention for Older Adults With Mild Cognitive Impairment: The CHOICE Randomized Clinical Trial

Await full published results before changing practice; this RCT directly tests whether hearing intervention stabilizes cognition in MCI, making it highly relevant, but actionability depends on the magnitude and direction of outcomes not yet fully available in this summary.

PubMed·Journal article·Clinical audiology·11d ago

Effect of selected components of aural rehabilitation delivered in-person versus guided internet-based modalities on quality of life in adults with hearing loss: a systematic review and meta-analyses

Clinicians can consider offering guided internet-based aural rehabilitation as a quality-of-life intervention for adults with hearing loss; the systematic review provides moderate-to-strong evidence that digital delivery is a viable alternative to in-person care, though effect...

PubMed·Journal article·Clinical audiology·4mo ago

Functional Benefits of Bilateral Bone Conduction Hearing Devices for Children and Adults With Conductive and Mixed Hearing Losses

Findings may support recommending bilateral (two-device) bone conduction fittings over unilateral for eligible patients with conductive or mixed hearing loss, but full results should be reviewed before changing fitting protocols.

PubMed·Journal article·Clinical audiology·3mo ago

Audiologic Assessment and Management of Teprotumumab-Associated Ototoxicity: An Updated Narrative Review

Audiologists should implement proactive baseline and monitoring audiologic assessments for patients prescribed teprotumumab, as ototoxicity risk is well-documented; this review provides updated clinical guidance on assessment and management strategies.

PubMed·Journal article·Clinical audiology·3mo ago

Development of a Visual Faces Scale for Adults with Hearing Loss: The Facial Scale of Hearing Difficulty

Consider evaluating the Facial Scale of Hearing Difficulty as a quick screening tool in busy clinic settings, particularly for patients who may struggle with traditional written questionnaires; however, await broader validation studies before replacing established tools.

PubMed·Journal article·Clinical audiology·4mo ago

Sudden Hearing Loss in Enlarged Vestibular Aqueduct Syndrome: A Systematic Review of Treatment and Outcomes

Audiologists and otolaryngologists managing patients with EVA and sudden hearing loss should note this review's synthesis of treatment outcomes, though the evidence base is likely limited by small, heterogeneous studies; current treatment decisions should be made in consultation...

PubMed·Journal article·Clinical audiology·2mo ago

Beyond steroid monotherapy: a systematic review and meta-analysis of combination therapy for severe to profound sudden sensorineural hearing loss

Audiologists and ENTs managing severe-to-profound sudden sensorineural hearing loss should be aware that this meta-analysis supports combination systemic plus intratympanic corticosteroid therapy over systemic steroids alone — referral pathways and counselling for at-risk...

PubMed·Journal article·Clinical audiology·2mo ago

Conventional Reporting Standards Conceal High-Frequency Hearing Deficits After Favorable Ossiculoplasty

Audiologists and surgeons should consider adding high-frequency pure-tone testing to routine post-ossiculoplasty outcome reporting, as standard four-frequency averages may mask clinically meaningful high-frequency deficits.